Scientists uncover potential new defence against hospital-acquired infections

Scientists uncover potential new defence against hospital-acquired infections

(Medical Xpress)—Infection specialists have uncovered new evidence about how the human body's immune system responds to invading germs – a finding which could help combat hospital-acquired infections in future.

The University of Glasgow team has been focusing on a particular pathogen – called Pseudomonas aeruginosa – which is the main cause of hospital-acquired pneumonia and has become increasingly resistant to antibiotics.

Critically-ill patients who are ventilated in intensive-care units are particularly vulnerable to this infection.

Now, however, a team led by Tom Evans, Professor of Molecular Microbiology, and Iraqi PhD researcher Majid Jabir, of the University's Institute of Infection, Immunity and Inflammation, have made an important breakthrough in understanding how the body's defensive response to infection works.

Their findings, which have been published in the U.S. journal Cell Host and Microbe, could potentially lead to new treatments.

Professor Evans explained: "Infection triggers a number of fundamental protective responses. One of these is the production of proteins, called 'cytokines', that help co-ordinate our to combat invading pathogens."

His team made what he describes as a "surprise finding" – that the activation system for producing certain cytokines in response to infection actually destroyed another key signalling protein within .

"This leads to down-regulation of a number of other cell processes," added Mr Jabir, who is the lead author for the paper, (Caspase-1 Cleavage of the TLR Adaptor TRIF Inhibits Autophagy and b-Interferon Production during Pseudomonas aeruginosa Infection).

The discovery of cross-talk between different elements of the defensive response to could potentially be exploited to develop new therapies against bacterial diseases. "This is a particularly pressing need given the rise in antibiotic resistance," added Mr Jabir.

More information: www.sciencedirect.com/science/… ii/S193131281400033X

add to favorites email to friend print save as pdf

Related Stories

Re-writing the research on the treatment of infection

Oct 10, 2013

(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with ...

Typhoid Fever: A race against time

Jan 16, 2014

The life-threatening disease typhoid fever results from the ongoing battle between the bacterial pathogen Salmonella and the immune cells of the body. Prof. Dirk Bumann's research group at the Biozentrum ...

Body's 'safety procedure' could explain autoimmune disease

Sep 05, 2013

Monash University researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments.

Recommended for you

Mystery of the reverse-wired eyeball solved

22 hours ago

From a practical standpoint, the wiring of the human eye - a product of our evolutionary baggage - doesn't make a lot of sense. In vertebrates, photoreceptors are located behind the neurons in the back of the eye - resulting ...

Neurons controlling appetite made from skin cells

22 hours ago

Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight ...

Quality control for adult stem cell treatment

Feb 27, 2015

A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.